Lab

NASHVILLE, Tenn.--(BUSINESS WIRE)--VION Biosciences, a life science platform company focused on specialty materials in the life science research, diagnostics, and drug discovery spaces, announced its January 2025 acquisition of San Francisco area-based BioAssay Systems, a biotech company that develops and offers innovative high-throughput assay solutions for life sciences and drug discovery. This acquisition serves as the fourth investment under the VION platform, continuing its growth in developing proprietary products for life science research.

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eufugiat nulla pariatur. Excepteur sint occaecat cupidatat non proidentsunt.